HCW BIOLOGICS INC's ticker is and the CUSIP is 40423R105. A total of 14 filers reported holding HCW BIOLOGICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $250,781 | -12.4% | 131,990 | 0.0% | 0.00% | – |
Q2 2023 | $286,418 | +1064.0% | 131,990 | +651.5% | 0.00% | – |
Q1 2023 | $24,607 | -26.8% | 17,564 | 0.0% | 0.00% | – |
Q4 2022 | $33,632 | -15.9% | 17,564 | 0.0% | 0.00% | -100.0% |
Q3 2022 | $40,000 | +2.6% | 17,564 | 0.0% | 0.00% | – |
Q2 2022 | $39,000 | -18.8% | 17,564 | 0.0% | 0.00% | – |
Q1 2022 | $48,000 | +65.5% | 17,564 | +40.5% | 0.00% | – |
Q4 2021 | $29,000 | – | 12,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 56,600 | $155,000 | 0.00% |
HighTower Advisors, LLC | 215,598 | $588,000 | 0.00% |
Focused Wealth Management, Inc | 1,000 | $3,000 | 0.00% |
UBS Group AG | 1,705 | $5,000 | 0.00% |
TWO SIGMA INVESTMENTS, LP | 51,200 | $140,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 44 | $0 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 53,169 | $145,000 | 0.00% |
STATE STREET CORP | 20,546 | $56,000 | 0.00% |
MORGAN STANLEY | 500 | $1,000 | 0.00% |